ARCUS BIOSCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02Results of Operations and Financial Condition.

On August 6, 2020, Arcus Biosciences, Inc. issued a press release announcing its financial results for the three and six months ended June 30, 2020. The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

The information in this Item 2.02 of this Form 8-K (including Exhibit 99.1) is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.   Description
99.1            Press release dated August 6, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses